IvanhoÃ© Cambridge, a global real estate subsidiary of Caisse de dÃ©pÃ´t et placement du QuÃ©bec (CDPQ), one of Canada’s leading institutional fund managers, has announced its entry into Genome Valley and has pledged to invest $ 100 million to develop approximately 1 million square feet of laboratory space in the life sciences cluster.
Genome Valley in Hyderabad is India’s first and largest hub for life science R&D and clean manufacturing, home to over 200 companies. The Telangana government has taken various initiatives to further strengthen the cluster.
Bharat Biotech will receive the Genome Valley Award of Excellence
Hyderabad strengthens its position as a global vaccine hub
A management team from IvanhoÃ© Cambridge and Lighthouse Canton, led by Chanakya Chakravarti, MD and Head of IvanhoÃ© Cambridge India, virtually interacted with Telangana Industries Minister KT Rama Rao today and made the announcement.
IvanhoÃ© Cambridge’s investment in MN Park in Genome Valley is in line with its global strategy of focusing on sectors that foster innovation and the fundamentals of long-term growth. This is one of the first such transactions by a pension fund in the life sciences real estate segment in South Asia and will set a benchmark for the industry in India. An investment of this nature strengthens Hyderabad’s leadership position in the life sciences sector.
IvanhoÃ© Cambridge brings deep expertise in real estate investing on a global scale. The company held C $ 60.4 billion in real estate assets as at December 31, 2020 and, through subsidiaries and partnerships, has an interest in more than 1,100 buildings, mainly in the industrial and logistics sectors, offices , residential and retail.
Minister Rama Rao, in a statement, said: âDelighted to announce the entry of IvanhoÃ© Cambridge, Canada into Genome Valley via MN Park with an investment commitment of $ 100 million.
“This new investment in MN Park, Hyderabad, allows us to strengthen our belief in life science real estate, a key area of ââour strategy to diversify into high growth and innovation driven sectors,” said Chakravarti. “We expect India and Hyderabad to further consolidate its position in the global life sciences arena in the post-pandemic world,” he added.